View Author
cancer breast breast cancer study family mutation brca 1 stage variant control association brca 2 mutations australia susceptibility research university genetic chek 2*1100delc department allele hospital individual breast cancer risk institute genet analysis nature table protein mrg 15 carrier centre 2*1100delc frequency sample genotype family history chek 2 stage 1 oncology subject result netherland brca 2 evidence population stage 2 victoria medicine genome-wide association study wales center model hapmap genotyped region morf 4l genome-wide women genotyping group pathway chromosome figure search stage 3 breast cancer cases disease genome locus ratio r 117g palb 2 statistic brca risk rad 51 score damage number breast cancer susceptibility
5 Most Recent Publications
|
Exploring the link between MORF4L1 and risk of breast cancer
(Article)
Martrat, G. Maxwell, C.A. Aguilar, H. Torres, D. Caligo, M.A. Godwin, A.K. Imyanitov, E.N. Janavicius, R. Sinilnikova, O. Stoppa-Lyonnet, D. Mazoyer, S. Verny-Pierre, C. Castera, L. Fernández-Rodríguez, J. Pauw, A. de Bignon, Y. Uhrhammer, N. Peyrat, J.-P. Vennin, P. Ferrer, S.F. Collonge-Rame, M.-A. Mortemousque, I. McGuffog, L. Chenevix-Trench, G. Seal, S. Pereira-Smith, O.M. Antoniou, A.C. Cerón, J. Surrallés, J. Pujana, M.A. Asperen, C.J. van Renwick, A. Rahman, N. Kühl, J. Neveling, K. Schindler, D. Ramírez, M.J. Castellà, M. Tominaga, E. Hernández, G. Easton, D.F. Peock, S. Cook, J. Oliver, C. Frost, D. Platte, R. Evans, D.G. Lalloo, F. Eeles, R. Porta-de-la-Riva, M. Izatt, L. Chu, C. Davidson, R. Ong, K. Douglas, F. Hodgson, S.V. Brewer, C. Morrison, P.J. Porteous, M.E. Peterlongo, P. Bonifaci, N. Manoukian, S. Peissel, B. Zaffaroni, D. Roversi, G. Barile, M. Viel, A. Pasini, B. Ottini, L. Putignano, A.L. Savarese, A. Gómez-Baldó, L. Bernard, L. Radice, P. Healey, S. Spurdle, A.B. Chen, X. Beesley, J. Rookus, M.A. Verhoef, S. Tilanus-Linthorst, M.M.A. Vreeswijk, M.P. Bogliolo, M. Bodmer, D. Ausems, M.G.E.M. Os, T.A.M. van Blok, M.J. Meijers-Heijboer, E.J. Hogervorst, F.B.L. Goldgar, D. Buys, S.S. John, E.M. Miron, A. Lázaro, C. Southey, M.C. Daly, M. Harbst, K. Borg, A. Rantala, J. Barbany-Bustinza, G. Ehrencrona, H. Stenmark-Askmalm, M. Kaufman, B. Laitman, Y. Blanco, I. Milgrom, R. Friedman, E. Domchek, S.M. Nathanson, K.L. Rebbeck, T.R. Johannsson, O.T. Couch, F.J. Wang, X. Fredericksen, Z. Cuadras, D. Brunet, J. Moreno, V. Pientka, F.K. Depping, R. Caldes, T. Osorio, A. Benítez, J. Bueren, J. Heikinen, T. Nevanlinna, H. Hamann, U. |
2011-04-05
|
|
Genome-wide association study identifies five new breast cancer susceptibility loci
(Article)
turnbull, C. Ahmed, S. Hughes, D. Warren-Perry, M. Tapper, W. Eccles, D. Evans, D.G. Hooning, M. Schutte, M. Ouweland, A.M.W. van den Houlston, R. Ross, G. Morrison, J. Langford, C. Pharoah, P.D.P. Stratton, M.R. Dunning, A.M. Rahman, N. Easton, D.F. Pernet, D. Renwick, A. Maranian, M. Seal, S. Ghoussaini, M. Hines, S. Healey, S. |
2010-06-01
|
|
Genome-wide association study identifies novel breast cancer susceptibility loci
(Article)
Easton, D.F. Pooley, K.A. Wareham, N.J. Conroy, D. Shah, M. Munday, H. Jordan, C. Perkins, B. West, J. Redman, K. Driver, K. Aghmesheh, M. Amor, D. Healey, S. Andrews, L. Antill, Y. Armes, J. Armitage, S. Arnold, L. Balleine, R. Begley, G. Beilby, J.P. Bennett, I. Berry, G. Bowman, R. Blackburn, A. Brown, M. Buckley, M. Burke, J. Butow, P. Byron, K. Callen, D.F. Campbell, I. Clarke, C. Colley, A. Meyer, K.B. Cotton, D. Cui, J. Culling, B. Cummings, M. Dawson, S.-J. Dixon, J. Dobrovic, A. Dudding, T. Edkins, T. Eisenbruch, M. Haiman, C.A. Farshid, G. Fawcett, S. Firgaira, F. Fleming, J. Forbes, J. Friedlander, M. Gaff, C. Gardner, M. Gattas, M. George, P. Kolonel, L.N. Gill, G. Goldblatt, J. Greening, S. Grist, S. Haan, E. Harris, M. Hart, S. Hayward, N. Humphrey, E. Jenkins, M.A. Henderson, B.E. Jones, A. Kefford, R. Kirk, J. Kollias, J. Kovalenko, S. Lakhani, S. Leary, J. Lim, J. Lindeman, G.J. Lipton, L. Le Marchand, L. Lobb, L. Maclurcan, M. Mann, G. Marsh, D. McKay, M.J. Anne McLachlan, S. Meiser, B. Mitchell, G. Newman, B. O'Loughlin, I. Brennan, P. Osborne, R.H. Peters, L. Phillips, K. Price, M. Reeve, J. Richards, R. Rinehart, G. Robinson, B. Rudzki, B. Salisbury, E. Sangrajrang, S. Sambrook, J. Saunders, C. Scott, C. Seshadri, R. Shelling, A. Suthers, G. Ahmed, S. Taylor, D. Tennant, C. Thorne, H. Dunning, A.M. Gaborieau, V. Townshend, S. Tucker, K. Tyler, J. Venter, D. Visvader, J. Walpole, I. Ward, R. Waring, P. Warner, B. Warren, G. Odefrey, F. Watson, E. Williams, R. Wilson, J. Winship, I.M. Young, M.A. Bowtell, D. Green, A. DeFazio, A. Gertig, D. Webb, P. Shen, C.Y. Wu, P.E. Wang, H.-C. Eccles, D. Evans, D.G. Peto, J. Fletcher, O. Johnson, N. Pharoah, P.D.P. Seal, S. Stratton, M.R. Rahman, N. Chenevix-Trench, G. Bojesen, S.E. Nordestgaard, B.G. Axelsson, C.K. García-Closas, M. Brinton, L.A. Chanock, S.J. Thompson, D. Lissowska, J. Peplonska, B. Nevanlinna, H. Fagerholm, R. Eerola, H. Kang, D. Yoo, K.Y. Noh, D.Y. Ahn, S.H. Hunter, D. Ballinger, D.G. Hankinson, S.E. Cox, D.G. Hall, P. Wedren, S. Liu, J. Low, Y.-L. Bogdanova, N.V. Schürmann, P. Dörk, T. Tollenaar, R.A.E.M. Struewing, J.P. Jacobi, C.E. Devilee, P. Klijn, J.G.M. Sigurdson, A.J. Doody, M. Alexander, B.H. Zhang, J. Brock, I.W. MacPherson, G. Reed, M.W.R. Morrison, J. Couch, F.J. Goode, E.L. Olson, J.E. Meijers-Heijboer, E.J. Ouweland, A.M.W. van den Uitterlinden, A.G. Rivadeneira Ramirez, F. Milne, R.L. Ribas, G. González-Neira, A. Field, H. Benítez, J. Hopper, J.L. McCredie, M. Southey, M.C. Giles, G.G. Schroen, C. Justenhoven, C. Brauch, H. Hamann, U. Ko, Y.D. Luben, R.N. Spurdle, A.B. Beesley, J. Chen, X. Mannermaa, A. Kosma, V.M. Kataja, V. Hartikainen, J. Day, N.E. Ponder, B.A.J. Luccarini, C. |
2007-06-28
|
|
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility
(Article)
Schutte, A.E.M. Meijers-Heijboer, E.J. Nathanson, K.L. Futreal, P.A. Stratton, M.R. Seal, S. Barfoot, R. Ouweland, A.M.W. van den Klijn, J.G.M. Easton, D.F. Wasielewski, M. Evans, D.G. Eccles, D. Weber, B.L. Rahman, N. Meijers, C. Lohman, F. |
2003-01-01
|
|
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
(Article)
Meijers-Heijboer, E.J. Snoo, A. de Schutte, M. McGuffog, L. Thompson, D. Easton, D.F. Sodha, N. Seal, S. Barfoot, R. Mangion, J. Chang-Claude, J. Eccles, D. Oldenburg, R. Eeles, R. Evans, D.G. Houlston, R. Murday, V. Narod, S. Peretz, T. Peto, J. Phelan, C. Zhang, H.X. Szabo, C. Hollestelle, A. Devilee, P. Goldgar, D. Futreal, P.A. Nathanson, K.L. Weber, B.L. Rahman, N. Stratton, M.R. Ouweland, A.M.W. van den Klijn, J.G.M. Wasielewski, M. Houben, M. Elstrodt, F. Crepin, E. Veghel-Plandsoen, M. van Duijn, C.M. van Bartels, C.C.M. Meijers, C. |
2002-05-01
|
